Evaluation of Subjective Ratings of Appetite and Glucoregulation of a Low Calorie Diet Supplemented With a High Viscosity Polysaccharide (PolyGlycopleX - PGX)
NCT ID: NCT01108328
Last Updated: 2015-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
35 participants
INTERVENTIONAL
2010-06-30
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia
NCT00801814
Investigating the Glycaemic and Satiating Capacity of PulseOn® Enriched Foods
NCT06508424
Effects of Viscous Fibre Containing Foods on Satiety (Gel Form)
NCT02134938
Satiety Study of a Carbohydrate Meal to a Highly Viscous Gel Meal
NCT01875627
Effect of Oligofructose on Appetite in Overweight Subjects
NCT00912197
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PolyGlycopleX (PGX)
5 grams of PGX 3 times per day with each main meal (breakfast, lunch and dinner)
PolyGlycopleX (PGX)
powder, 5 grams, 3 times per day at each main meal (breakfast, lunch and dinner) for a total of 3 days
Rice flour
5 grams of rice flour 3 times per day at each main meal (breakfast, lunch and dinner)
PolyGlycopleX (PGX)
powder, 5 grams, 3 times per day at each main meal (breakfast, lunch and dinner) for a total of 3 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PolyGlycopleX (PGX)
powder, 5 grams, 3 times per day at each main meal (breakfast, lunch and dinner) for a total of 3 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Medications or natural health products that affect appetite
* Contraindications to LCD
* Any other medical, social or geographic condition, which, in the opinion of the investigator would not allow safe completion of the protocol.
20 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
InovoBiologic Inc.
INDUSTRY
Canadian Center for Functional Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Lyon, MD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Canadian Centre for Functional Medicine
Coquitlam, British Columbia, Canada
Canadian Center for Functional Medicine
Coquitlam, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kacinik V, Lyon M, Purnama M, Reimer RA, Gahler R, Green TJ, Wood S. Effect of PGX, a novel functional fibre supplement, on subjective ratings of appetite in overweight and obese women consuming a 3-day structured, low-calorie diet. Nutr Diabetes. 2011 Dec 12;1(12):e22. doi: 10.1038/nutd.2011.18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PGX Crossover Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.